In this week’s episode, (part 2 to Episode #42)...

Nathalie continues her conversation with Dr. Lawrence about Russian Bioregulator peptides and the role they may play in reversing biological age in humans. They review several different studies, discuss organ regeneration as well as how precisely designed BioRegulator Peptide cycles have so far affected DNA methylation patterns in Clinical Trial participants.

Meet This Week's Guest

Dr. Lawrence has a Jurisprudence Degree (UCLA-Law), an MS in Psychology and a Ph.D. in Nutrition with a particular interest in Longevity. Since 1990 his focus has been on slowing and reversing human biological aging. 3 years ago he started a human clinical trial in collaboration with Dr Vladimir Khavinson from the Saint Petersburg Institute of He has developed numerous science-based protocols focused on optimal aging for health professionals and individual clients.

Presently Dr. Lawrence is the administrator of two clinical studies to determine if human biological age can be reversed. NB- Dr. Lawrence’s chronological age is 74. His ‘biological age,’ based on his telomere length is 35.

To buy the Nature's Marvels Bioregulator Peptides that Dr Lawrence uses in his trial you can click here or go to Profound-Health.com and use discount code Longevity15 to save 15% off your first order

Key Takeaways

If possible, it is best to watch this podcast on YouTube as well so that you can see the slides. There is a slide for all the highlights.

[1:04] About Dr. Lawrence and a brief overview of what was talked about last episode…

[8:00] Telomerase Activation and DNA Methylation Longevity Interventions…

[9:00] Theories of aging/ways to intervene in the aging process…

[10:36] St. Petersburg Institute of Bioregulation and Gerontology…

[11:42] Vladimir Khavison, who he is and what he does…

[13:30] What are peptides?...

[14:00] What was the catalyst for creating bioregulator peptides? The program that created them and some of the first test subjects…

[18:19] How your body uses amino acids as building blocks…

[20:15] Photo of DNA and bioregulator peptide and how they fit together…

[21:15] The influence of peptide bioregulators on morbidity…

[24:11] Can peptide bioregulators restore retinal function?…

[29:30] How are bioregulator peptides sourced?..

[29:34] Epigenetic methylation study, what methylation effects in the body and what can affect methylation…

[39:05] Want to know when you are going to die?..

[44:00] How much do your genes control when it comes to health?..

[49:25] Epigenetic study on gene expression during aging… Looking at DNA age vs chronological age…

[64:58] Human lifespan potential study published by the Smithsonian Magazine…

[66:55] Organ regeneration with bioregulator peptides…

[79:45] Can we live 150 years?.. What can we do to make that happen?..

[89:04] Do some peptides make other peptides more effective?..

[90:00] Nathalie fires off some closing questions such as are allergic reactions possible with bioregulators?…

To purchase Bioregulator Peptides you can use this link https://bit.ly/BioregNN and discount code Longevity15 to save 15% off your first order!

EPISODE SPONSOR:

drinkHRW: For the past 4 years I have been using molecular hydrogen tablets every single day for dozens of reasons including mitigation of oxidative stress, to support my mitochondria and metabolic health, to help me recover from my workouts ....I have every one of my clients using drinkHRW tablets and they all love them too!

Check out their amazing products at drinkHRW.com and use promo code Longevity10 to get 10% off your purchase!

Disclaimer: This podcast and the information presented are for informational purposes only and not intended to diagnose or treat disease. Before making any changes to your nutrition or supplementation please check with your physician or health provider.

Dr Bill Lawrence: Reversing Aging PART 2 Bioregulator Peptides Effect on DNA Methylation Clinical Trial

LONGEVITY with Nathalie Niddam

Dr Bill Lawrence: Reversing Aging PART 2 Bioregulator Peptides Effect on DNA Methylation Clinical Trial